Nasdaq
$3.33▼ 0.37%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.24BShares out 3.700M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 4d agoAfter-hours26.10.21 06:224Ownership#●●●
Cronos Group Inc.
Cronos Group Inc. insider Christopher Martens filed a Form 4 on October 20, 2026, reporting a change in beneficial ownership of securities as of October 16, 2026. This filing serves as a standard disclosure of changes in equity holdings by company management.…more
$3.33-0.37%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 4d agoAfter-hours26.10.21 06:213Ownership
Cronos Group Inc.
Insider Christopher Martens of Cronos Group Inc. has filed a Form 3 to report his initial statement of beneficial ownership of securities. This filing serves as an official disclosure of the insider's holdings and does not indicate a direct change in the company's control or capital structure.…more
$3.33-0.37%vs prev closeView filingShare - 10.15Pre-market26.10.15 20:028-KKey event
Cronos Group Inc.
Cronos Group has completed the acquisition of CanAdelaar B.V., a leader in the Netherlands' adult-use cannabis pilot program, for a base purchase price of 57.5 million euros. This acquisition establishes a strategic European platform for Cronos, with additional contingent consideration payable in cash equal to 50% of CanAdelaar's normalized EBITDA for 2026 and 2027.…more
$3.33-0.37%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.15Pre-market26.10.15 20:00#●●●#●●●
Cronos Group Completes Acquisition of Dutch Cannabis Firm CanAdelaar
Cronos Group has finalized its acquisition of CanAdelaar, a leading operator in the Netherlands' cannabis pilot program, for €57.5 million. This deal establishes a strategic European platform for the company, though the long-term financial impact remains subject to operational integration.…more
$3.33-0.37%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.13Pre-market26.10.13 20:30
●●●●●●●● ●●●●● ●●●●●●
Cronos Group is bringing back its popular seasonal green apple-flavored edibles and vape products for the fall. While the company aims to leverage existing brand popularity, the impact on overall financial performance remains to be seen.…more
$3.33-0.37%vs prev close - 10.8Pre-market26.10.08 20:30
●●●●●●●● ●●●●● ●●●●●●
Cronos Group has scheduled its third-quarter 2026 earnings conference call for November 5. Management will discuss the company's financial results and host a Q&A session for investors.…more
$3.33-0.37%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report